The DOI matches its Crossref record.
Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A Report of Excellence
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An exemption refers to 8 cases of HILI by Indian products as reported in a RUCAM-based prospective study by the Indian group of Rathi et al. that was classified as a report of excellence.
“An exemption refers to 8 cases of HILI by Indian products as reported in a RUCAM-based prospective study by the Indian group of Rathi et al.62 that was classified as a report of excellence.63”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 15
- Rathi, 2017, Drug induced liver injury at a tertiary hospital in India: Etiology, clinical features and predictors of mortality, Ann Hepatol, 16, 442, 10.5604/01.3001.0009.8600 · DOI · Paper page
- Danan, 1993, Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
- Bénichou, 1993, Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
- Danan, 2016, RUCAM in drug and herb induced liver injury: the update, Int J Mol Sci; Special issue: Drug, herb, and dietary supplement hepatotoxicity, 17, 14, 10.3390/ijms17010014 · DOI · Paper page
- Björnsson, 2012, Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing, J Hepatol, 56, 374, 10.1016/j.jhep.2011.07.023 · DOI
- Andrade, 2005, Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period, Gastroenterology, 129, 512, 10.1016/j.gastro.2005.05.006 · DOI · Paper page
- Zhu, 2016, Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients, J Gastro-enterol Hepatol, 31, 1476, 10.1111/jgh.13323 · DOI · Paper page
- Teschke, 2014, Drug induced liver injury: accuracy of diagnosis in published reports, Ann Hepatol, 13, 248, 10.1016/S1665-2681(19)30888-9 · DOI
- Björnsson, 2016, Hepatotoxicity by drugs: the most common implicated agents, Int J Mol Sci, 17, 224, 10.3390/ijms17020224 · DOI · Paper page
- Teschke, 2013, Herbal hepatotoxicity: suspected cases assessed for alternative causes, Eur J Gastroenterol Hepatol, 25, 1093, 10.1097/MEG.0b013e3283603e89 · DOI
- Zambrone, 2015, A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife products, Braz J Pharm Sci, 51, 10.1590/S1984-82502015000400004 · DOI
- Teschke, 2016, The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem, Ann Hepatol, 15, 91, 10.5604/16652681.1184237 · DOI · Paper page
- Teschke, 2016, The Honolulu Liver disease cluster at the Medical Center: Its mysteries and challenges, Int J Mol Sci, 17, 476, 10.3390/ijms17040476 · DOI · Paper page
- Teschke, 2017, Suspected liver injury and the dilemma of causality, Dig Dis Sci, 62, 1095, 10.1007/s10620-016-4442-5 · DOI
- Teschke, 2016, Traditional Chinese Medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs, Medicines, 3
Cited by
Sorted by citations
Teschke, R., Zhu, Y., & Jing, J. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00009 · Cited by 41
Self-citation
Metadata
- Authors
- Teschke, R., & Danan, G.
- Venue
- Annals of Hepatology
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 16
- Issue
- 3
- Pages
- 324-325
- ISSN
- 1665-2681
- Cited by
- 14
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
